Find the investors funding Health rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Jülich-based SRTD Biotech secures €31.5 million to develop precision mRNA therapies targeting diseased cells - EU-Startups
SRTD Biotech is focused on developing precision mRNA therapies that target diseased cells. The company aims to innovate in the biotech sector by leveraging mRNA technology to create effective treatments for various diseases.
Jülich-based SRTD Biotech secures €31.5 million to develop precision mRNA therapies targeting diseased cells EU-Startups
| Nov 20, 2026 | Daisytuner | $6.0M | Seed | Germany |
| Nov 19, 2026 | Vetaion | $6.2M | — | Germany |
| Nov 15, 2026 | Tendos | $13.0M | Seed | Germany |
| Nov 13, 2026 | NeuralSat | $3.1M | — | Germany |
You just read who funded SRTD Biotech. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.